Mark K. Weng
Impact in
- Hepatology top 2%
- Hepatitis Viruses Studies and Epidemiology
- Hepatitis C virus research
- Liver Disease and Transplantation
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
- Epidemiology 17
- Hepatitis B Virus Studies 13
- HIV, Drug Use, Sexual Risk 3
- Hepatology 17
- Hepatitis Viruses Studies and Epidemiology 15
- Hepatitis C virus research 6
- Co-authors
- Noele P. Nelson (10 shared papers)Mona Doshani (6 shared papers)Kelly L. Moore (4 shared papers)José R. Romero (2 shared papers)Megan G. Hofmeister (6 shared papers)Sarah Schillie (3 shared papers)Alaya Koneru (2 shared papers)Aaron M. Harris (2 shared papers)
- Journals
- MMWR Morbidity and Mortality Weekly Report (3 papers)Vaccine (2 papers)Hepatology (2 papers)Public Health Reports (2 papers)The Journal of Infectious Diseases (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark K. Weng
23 papers receiving 463 citations
Mark K. Weng's Hit Papers
Peers
Comparison fields: 5 of 72
- Hepatology 322
- Health 95
- Epidemiology 347
- Infectious Diseases 123
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Mark K. Weng
This map shows the geographic impact of Mark K. Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Weng more than expected).
Fields of papers citing papers by Mark K. Weng
This network shows the impact of papers produced by Mark K. Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Weng. The network helps show where Mark K. Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark K. Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 137 | |
| 2 | Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Hit paper breakdown → | 2022 | 110 |
| 3 | 2019 | 55 | |
| 4 | 2020 | 33 | |
| 5 | 2022 | 31 | |
| 6 | 2020 | 17 | |
| 7 | 2022 | 16 | |
| 8 | 2019 | 13 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2018 | 4 | |
| 16 | 2012 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2021 | 1 |
About Mark K. Weng
Mark K. Weng is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Health and General Health Professions, having authored 24 papers that have together received 478 indexed citations. Recurring topics across this work include Hepatitis Viruses Studies and Epidemiology (15 papers), Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (6 papers), Vaccine Coverage and Hesitancy (5 papers), HIV, Drug Use, Sexual Risk (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Homelessness and Social Issues (3 papers) and Nosocomial Infections in ICU (2 papers). The work is most often cited by research in Hepatology (322 citations), Health (95 citations), Epidemiology (347 citations), Infectious Diseases (123 citations) and Applied Microbiology and Biotechnology (6 citations). Mark K. Weng has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Noele P. Nelson, Mona Doshani, Kelly L. Moore, José R. Romero, Megan G. Hofmeister, Sarah Schillie, Alaya Koneru, Aaron M. Harris, Eric Hall and Rebecca L. Morgan. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Vaccine, Hepatology, Public Health Reports and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.